Researchers out of Hamilton, Ontario's McMaster University and The Society for Evidence Based Medicine (SEGM) used a systematic review method called "meta-analysis" to assess a host of existing studies, which once again showed that there is poor evidence for the use of both GnRH Analogues (puberty blockers) and synthetic sex hormones for young people experiencing transgender ideation, commonly referred to as gender dysphoria (GD).